Avalon will attend the 30th Semi-Annual Diagnostic Coverage and Reimbursement Conference to participate in discussions focused on understanding fluctuations in Payer and LBM Policies, the incorporation of FDA oversight of LDTs into payment frameworks, the impact of state biomarker laws on organizational policy, the significance of breakthrough designation for commercial plans, and more.
Events
30th Semi-Annual Q1 Productions Diagnostic Reimbursement Conference
May 21 – 22, 2025
| Chicago, IL
Event Details
May 21 – 22, 2025
Chicago, IL
To register, please visit Q1 Diagnostics.